Harvard University School of Medicine, Boston, MA, USA.
J Int AIDS Soc. 2013 Sep 3;16(1):17325. doi: 10.7448/IAS.16.1.17325.
Papulopruritic eruption (PPE) occurs in people living with HIV in India. Understanding the risk factors associated with this disease may help decrease the prevalence of PPE.
This study was a case-control study performed at the Government Hospital of Thoracic Medicine, a tertiary care hospital in Chennai, India. Cases included HIV-positive, antiretroviral (ARV) therapy-naïve adults experiencing a pruritic skin eruption for longer than one month, with evidence of multiple papular or nodular lesions and biopsy consistent with arthropod bite. Controls included HIV-positive, ARV-naïve patients without active skin rash. Main outcome measures were CD4 cell count, histology, and environmental exposures. We performed statistical analysis using Epi Info version 3.5.1 and SPSS version 11.0 (SPSS Inc., Chicago, IL). Categorical variables such as gender, urban versus rural residence, occupation, treatment history, CD4 count, use of insect repellents, and environmental exposures were evaluated using the χ(2) test (or the Fisher exact test when an expected value for a category was less than 5). The t-test was used to evaluate differences in age and the duration since HIV diagnosis. The Mann-Whitney test was used to compare non-normally distributed values such as CD4 cell count. A p-value that was less than 0.05 was considered to be statistically significant.
Forty-one cases and 149 control subjects were included. Subjects with PPE had significantly lower CD4 cell counts compared to controls (225.5 cells/µL vs. 425 cells/µL; p=0.0001). Sixty-six percent of cases had a CD4 cell count less than 350 cells/µL. PPE cases were less likely to use mosquito repellent techniques (odds ratio 2.81, CI = 1.45-5.45).
PPE may be an altered and exaggerated immune response to arthropod bites in HIV-positive patients. CD4 cell count is significantly lower in patients with PPE, and therefore it may be considered a qualifying clinical finding for ARV initiation in resource-poor settings. Protective measures against mosquito bites appeared to be important in preventing PPE in subjects at risk.
在印度,艾滋病毒感染者会出现丘疹脓疱疹(PPE)。了解与这种疾病相关的危险因素可能有助于降低 PPE 的发病率。
本研究为病例对照研究,在印度钦奈的一家三级保健医院——胸科医院进行。病例包括 CD4 细胞计数为阳性、未接受抗逆转录病毒(ARV)治疗的成年人,他们出现瘙痒性皮疹超过一个月,伴有多个丘疹或结节性病变的证据,且活检符合节肢动物咬伤。对照包括 CD4 细胞计数为阳性、未接受抗逆转录病毒治疗的无活动性皮疹的患者。主要观察指标为 CD4 细胞计数、组织学和环境暴露。我们使用 Epi Info 版本 3.5.1 和 SPSS 版本 11.0(SPSS Inc.,芝加哥,IL)进行统计分析。使用 χ²检验(当一个类别中的预期值小于 5 时使用 Fisher 确切检验)评估性别、城市与农村居住、职业、治疗史、CD4 计数、使用驱虫剂和环境暴露等分类变量。使用 t 检验评估年龄和从 HIV 诊断到现在的时间差异。使用 Mann-Whitney 检验比较 CD4 细胞计数等非正态分布值。p 值小于 0.05 被认为具有统计学意义。
纳入 41 例病例和 149 例对照。与对照组相比,PPE 患者的 CD4 细胞计数明显更低(225.5 个/µL 与 425 个/µL;p=0.0001)。66%的病例 CD4 细胞计数小于 350 个/µL。PPE 患者使用驱蚊技术的可能性较低(比值比 2.81,CI=1.45-5.45)。
PPE 可能是 HIV 阳性患者对节肢动物叮咬的改变和过度免疫反应。PPE 患者的 CD4 细胞计数明显较低,因此在资源匮乏的环境中,可能会考虑将其作为启动 ARV 治疗的一个临床指征。针对蚊子叮咬的预防措施对防止高危人群出现 PPE 可能很重要。